Global and Japan Pirfenidone Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Oct-2021
No. of pages: 140
Inquire Before Buying

Pirfenidone market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pirfenidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Pirfenidone market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Tablet

- Capsule

- Other

Segment by Application

- Mild Idiopathic Pulmonary Fibrosis

- Moderate Idiopathic Pulmonary Fibrosis

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Genentech (Roche)

- Shionogi

- GNI Group

- Beijing Continent

- Cipla

- Lupin Ltd

- Zydus Cadila

- Glenmark Pharmaceuticals

- Koye Pharmaceuticals

- MSN Laboratories

- Wockhardt

- Incepta Pharmaceuticals

- Unimed Unihealth

Global and Japan Pirfenidone Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Pirfenidone Product Introduction
1.2 Market by Type
1.2.1 Global Pirfenidone Market Size Growth Rate by Type
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Pirfenidone Market Size Growth Rate by Application
1.3.2 Mild Idiopathic Pulmonary Fibrosis
1.3.3 Moderate Idiopathic Pulmonary Fibrosis
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pirfenidone Market Size, Estimates and Forecasts
2.1.1 Global Pirfenidone Revenue 2016-2027
2.1.2 Global Pirfenidone Sales 2016-2027
2.2 Global Pirfenidone, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Pirfenidone Historical Market Size by Region (2016-2021)
2.3.1 Global Pirfenidone Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Pirfenidone Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Pirfenidone Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Pirfenidone Sales Forecast by Region (2022-2027)
2.4.2 Global Pirfenidone Revenue Forecast by Region (2022-2027)
3 Global Pirfenidone Competitor Landscape by Players
3.1 Global Top Pirfenidone Manufacturers by Sales
3.1.1 Global Pirfenidone Sales by Manufacturer (2016-2021)
3.1.2 Global Pirfenidone Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Pirfenidone Manufacturers by Revenue
3.2.1 Key Pirfenidone Manufacturers Covered: Ranking by Revenue
3.2.2 Global Pirfenidone Revenue by Manufacturers (2016-2021)
3.2.3 Global Pirfenidone Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pirfenidone Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Pirfenidone Revenue in 2020
3.2.6 Global Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Pirfenidone Price by Manufacturers
3.4 Global Pirfenidone Manufacturing Base Distribution, Product Types
3.4.1 Pirfenidone Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pirfenidone Product Type
3.4.3 Date of International Manufacturers Enter into Pirfenidone Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Pirfenidone Market Size by Type (2016-2021)
4.1.1 Global Pirfenidone Sales by Type (2016-2021)
4.1.2 Global Pirfenidone Revenue by Type (2016-2021)
4.1.3 Pirfenidone Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Pirfenidone Market Size Forecast by Type (2022-2027)
4.2.1 Global Pirfenidone Sales Forecast by Type (2022-2027)
4.2.2 Global Pirfenidone Revenue Forecast by Type (2022-2027)
4.2.3 Pirfenidone Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Pirfenidone Market Size by Application (2016-2021)
5.1.1 Global Pirfenidone Sales by Application (2016-2021)
5.1.2 Global Pirfenidone Revenue by Application (2016-2021)
5.1.3 Pirfenidone Price by Application (2016-2021)
5.2 Pirfenidone Market Size Forecast by Application (2022-2027)
5.2.1 Global Pirfenidone Sales Forecast by Application (2022-2027)
5.2.2 Global Pirfenidone Revenue Forecast by Application (2022-2027)
5.2.3 Global Pirfenidone Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Pirfenidone Market Size YoY Growth 2016-2027
6.1.1 Japan Pirfenidone Sales YoY Growth 2016-2027
6.1.2 Japan Pirfenidone Revenue YoY Growth 2016-2027
6.1.3 Japan Pirfenidone Market Share in Global Market 2016-2027
6.2 Japan Pirfenidone Market Size by Players (International and Local Players)
6.2.1 Japan Top Pirfenidone Players by Sales (2016-2021)
6.2.2 Japan Top Pirfenidone Players by Revenue (2016-2021)
6.3 Japan Pirfenidone Historic Market Review by Type (2016-2021)
6.3.1 Japan Pirfenidone Sales Market Share by Type (2016-2021)
6.3.2 Japan Pirfenidone Revenue Market Share by Type (2016-2021)
6.3.3 Japan Pirfenidone Price by Type (2016-2021)
6.4 Japan Pirfenidone Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Pirfenidone Sales Forecast by Type (2022-2027)
6.4.2 Japan Pirfenidone Revenue Forecast by Type (2022-2027)
6.4.3 Japan Pirfenidone Price Forecast by Type (2022-2027)
6.5 Japan Pirfenidone Historic Market Review by Application (2016-2021)
6.5.1 Japan Pirfenidone Sales Market Share by Application (2016-2021)
6.5.2 Japan Pirfenidone Revenue Market Share by Application (2016-2021)
6.5.3 Japan Pirfenidone Price by Application (2016-2021)
6.6 Japan Pirfenidone Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Pirfenidone Sales Forecast by Application (2022-2027)
6.6.2 Japan Pirfenidone Revenue Forecast by Application (2022-2027)
6.6.3 Japan Pirfenidone Price Forecast by Application (2022-2027)
7 North America
7.1 North America Pirfenidone Market Size YoY Growth 2016-2027
7.2 North America Pirfenidone Market Facts & Figures by Country
7.2.1 North America Pirfenidone Sales by Country (2016-2021)
7.2.2 North America Pirfenidone Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Pirfenidone Market Size YoY Growth 2016-2027
8.2 Asia Pacific Pirfenidone Market Facts & Figures by Region
8.2.1 Asia Pacific Pirfenidone Sales by Region (2016-2021)
8.2.2 Asia Pacific Pirfenidone Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Pirfenidone Market Size YoY Growth 2016-2027
9.2 Europe Pirfenidone Market Facts & Figures by Country
9.2.1 Europe Pirfenidone Sales by Country (2016-2021)
9.2.2 Europe Pirfenidone Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Pirfenidone Market Size YoY Growth 2016-2027
10.2 Latin America Pirfenidone Market Facts & Figures by Country
10.2.1 Latin America Pirfenidone Sales by Country (2016-2021)
10.2.2 Latin America Pirfenidone Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pirfenidone Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Pirfenidone Market Facts & Figures by Country
11.2.1 Middle East and Africa Pirfenidone Sales by Country (2016-2021)
11.2.2 Middle East and Africa Pirfenidone Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Genentech (Roche)
12.1.1 Genentech (Roche) Corporation Information
12.1.2 Genentech (Roche) Description and Business Overview
12.1.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Genentech (Roche) Pirfenidone Products Offered
12.1.5 Genentech (Roche) Recent Development
12.2 Shionogi
12.2.1 Shionogi Corporation Information
12.2.2 Shionogi Description and Business Overview
12.2.3 Shionogi Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shionogi Pirfenidone Products Offered
12.2.5 Shionogi Recent Development
12.3 GNI Group
12.3.1 GNI Group Corporation Information
12.3.2 GNI Group Description and Business Overview
12.3.3 GNI Group Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GNI Group Pirfenidone Products Offered
12.3.5 GNI Group Recent Development
12.4 Beijing Continent
12.4.1 Beijing Continent Corporation Information
12.4.2 Beijing Continent Description and Business Overview
12.4.3 Beijing Continent Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Beijing Continent Pirfenidone Products Offered
12.4.5 Beijing Continent Recent Development
12.5 Cipla
12.5.1 Cipla Corporation Information
12.5.2 Cipla Description and Business Overview
12.5.3 Cipla Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cipla Pirfenidone Products Offered
12.5.5 Cipla Recent Development
12.6 Lupin Ltd
12.6.1 Lupin Ltd Corporation Information
12.6.2 Lupin Ltd Description and Business Overview
12.6.3 Lupin Ltd Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lupin Ltd Pirfenidone Products Offered
12.6.5 Lupin Ltd Recent Development
12.7 Zydus Cadila
12.7.1 Zydus Cadila Corporation Information
12.7.2 Zydus Cadila Description and Business Overview
12.7.3 Zydus Cadila Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zydus Cadila Pirfenidone Products Offered
12.7.5 Zydus Cadila Recent Development
12.8 Glenmark Pharmaceuticals
12.8.1 Glenmark Pharmaceuticals Corporation Information
12.8.2 Glenmark Pharmaceuticals Description and Business Overview
12.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Glenmark Pharmaceuticals Pirfenidone Products Offered
12.8.5 Glenmark Pharmaceuticals Recent Development
12.9 Koye Pharmaceuticals
12.9.1 Koye Pharmaceuticals Corporation Information
12.9.2 Koye Pharmaceuticals Description and Business Overview
12.9.3 Koye Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Koye Pharmaceuticals Pirfenidone Products Offered
12.9.5 Koye Pharmaceuticals Recent Development
12.10 MSN Laboratories
12.10.1 MSN Laboratories Corporation Information
12.10.2 MSN Laboratories Description and Business Overview
12.10.3 MSN Laboratories Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.10.4 MSN Laboratories Pirfenidone Products Offered
12.10.5 MSN Laboratories Recent Development
12.11 Genentech (Roche)
12.11.1 Genentech (Roche) Corporation Information
12.11.2 Genentech (Roche) Description and Business Overview
12.11.3 Genentech (Roche) Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Genentech (Roche) Pirfenidone Products Offered
12.11.5 Genentech (Roche) Recent Development
12.12 Incepta Pharmaceuticals
12.12.1 Incepta Pharmaceuticals Corporation Information
12.12.2 Incepta Pharmaceuticals Description and Business Overview
12.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Incepta Pharmaceuticals Products Offered
12.12.5 Incepta Pharmaceuticals Recent Development
12.13 Unimed Unihealth
12.13.1 Unimed Unihealth Corporation Information
12.13.2 Unimed Unihealth Description and Business Overview
12.13.3 Unimed Unihealth Pirfenidone Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Unimed Unihealth Products Offered
12.13.5 Unimed Unihealth Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Pirfenidone Industry Trends
13.2 Pirfenidone Market Drivers
13.3 Pirfenidone Market Challenges
13.4 Pirfenidone Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pirfenidone Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Pirfenidone Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Capsule
Table 4. Major Manufacturers of Other
Table 5. Global Pirfenidone Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 6. Global Pirfenidone Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Pirfenidone Sales by Regions (2016-2021) & (K Pcs)
Table 8. Global Pirfenidone Sales Market Share by Regions (2016-2021)
Table 9. Global Pirfenidone Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Pirfenidone Sales Forecast by Region (2022-2027) & (K Pcs)
Table 11. Global Pirfenidone Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Pirfenidone Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Pirfenidone Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Pirfenidone Sales by Manufacturers (2016-2021) (K Pcs)
Table 15. Global Pirfenidone Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Pirfenidone Manufacturers by Revenue (US$ Million) in 2020
Table 17. Pirfenidone Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Pirfenidone Revenue Share by Manufacturers (2016-2021)
Table 19. Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Pirfenidone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pirfenidone as of 2020)
Table 21. Key Manufacturers Pirfenidone Price (2016-2021) (USD/Pcs)
Table 22. Pirfenidone Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pirfenidone Product Type
Table 24. Date of International Manufacturers Enter into Pirfenidone Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Pirfenidone Sales by Type (2016-2021) (K Pcs)
Table 27. Global Pirfenidone Sales Share by Type (2016-2021)
Table 28. Global Pirfenidone Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Pirfenidone Revenue Share by Type (2016-2021)
Table 30. Pirfenidone Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 31. Global Pirfenidone Sales Forecast by Type (2022-2027) & (K Pcs)
Table 32. Global Pirfenidone Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Pirfenidone Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Pirfenidone Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Pirfenidone Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 36. Global Pirfenidone Sales by Application (2016-2021) (K Pcs)
Table 37. Global Pirfenidone Sales Share by Application (2016-2021)
Table 38. Global Pirfenidone Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Pirfenidone Revenue Share by Application (2016-2021)
Table 40. Pirfenidone Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 41. Global Pirfenidone Sales Forecast by Application (2022-2027) & (K Pcs)
Table 42. Global Pirfenidone Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Pirfenidone Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Pirfenidone Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Pirfenidone Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 46. Japan Pirfenidone Sales (K Pcs) of Key Companies (2016-2021)
Table 47. Japan Pirfenidone Sales Share by Company (2016-2021)
Table 48. Japan Pirfenidone Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Pirfenidone Revenue Share by Company (2016-2021)
Table 50. Japan Pirfenidone Sales (K Pcs) by Type (2016-2021)
Table 51. Japan Pirfenidone Sales Share by Type (2016-2021)
Table 52. Japan Pirfenidone Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Pirfenidone Price (USD/Pcs) by Type (2016-2021)
Table 54. Japan Pirfenidone Sales (K Pcs) by Type (2022-2027)
Table 55. Japan Pirfenidone Sales Share by Type (2022-2027)
Table 56. Japan Pirfenidone Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Pirfenidone Revenue Share by Type (2022-2027)
Table 58. Japan Pirfenidone Price (USD/Pcs) by Type (2022-2027)
Table 59. Japan Pirfenidone Sales (K Pcs) by Application (2016-2021)
Table 60. Japan Pirfenidone Sales Share by Application (2016-2021)
Table 61. Japan Pirfenidone Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Pirfenidone Price (USD/Pcs) by Application (2016-2021)
Table 63. Japan Pirfenidone Sales (K Pcs) by Application (2022-2027)
Table 64. Japan Pirfenidone Sales Share by Application (2022-2027)
Table 65. Japan Pirfenidone Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Pirfenidone Revenue Share by Application (2022-2027)
Table 67. Japan Pirfenidone Price (USD/Pcs) by Application (2022-2027)
Table 68. North America Pirfenidone Sales by Country (2016-2021) & (K Pcs)
Table 69. North America Pirfenidone Sales Market Share by Country (2016-2021)
Table 70. North America Pirfenidone Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Pirfenidone Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Pirfenidone Sales by Region (2016-2021) & (K Pcs)
Table 73. Asia Pacific Pirfenidone Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Pirfenidone Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Pirfenidone Revenue Market Share by Region (2016-2021)
Table 76. Europe Pirfenidone Sales by Country (2016-2021) & (K Pcs)
Table 77. Europe Pirfenidone Sales Market Share by Country (2016-2021)
Table 78. Europe Pirfenidone Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Pirfenidone Revenue Market Share by Country (2016-2021)
Table 80. Latin America Pirfenidone Sales by Country (2016-2021) & (K Pcs)
Table 81. Latin America Pirfenidone Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Pirfenidone Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Pirfenidone Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Pirfenidone Sales by Country (2016-2021) & (K Pcs)
Table 85. Middle East and Africa Pirfenidone Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Pirfenidone Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Pirfenidone Revenue Market Share by Country (2016-2021)
Table 88. Genentech (Roche) Corporation Information
Table 89. Genentech (Roche) Description and Business Overview
Table 90. Genentech (Roche) Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Genentech (Roche) Pirfenidone Product
Table 92. Genentech (Roche) Recent Development
Table 93. Shionogi Corporation Information
Table 94. Shionogi Description and Business Overview
Table 95. Shionogi Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Shionogi Product
Table 97. Shionogi Recent Development
Table 98. GNI Group Corporation Information
Table 99. GNI Group Description and Business Overview
Table 100. GNI Group Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. GNI Group Product
Table 102. GNI Group Recent Development
Table 103. Beijing Continent Corporation Information
Table 104. Beijing Continent Description and Business Overview
Table 105. Beijing Continent Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Beijing Continent Product
Table 107. Beijing Continent Recent Development
Table 108. Cipla Corporation Information
Table 109. Cipla Description and Business Overview
Table 110. Cipla Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Cipla Product
Table 112. Cipla Recent Development
Table 113. Lupin Ltd Corporation Information
Table 114. Lupin Ltd Description and Business Overview
Table 115. Lupin Ltd Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Lupin Ltd Product
Table 117. Lupin Ltd Recent Development
Table 118. Zydus Cadila Corporation Information
Table 119. Zydus Cadila Description and Business Overview
Table 120. Zydus Cadila Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Zydus Cadila Product
Table 122. Zydus Cadila Recent Development
Table 123. Glenmark Pharmaceuticals Corporation Information
Table 124. Glenmark Pharmaceuticals Description and Business Overview
Table 125. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Glenmark Pharmaceuticals Product
Table 127. Glenmark Pharmaceuticals Recent Development
Table 128. Koye Pharmaceuticals Corporation Information
Table 129. Koye Pharmaceuticals Description and Business Overview
Table 130. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. Koye Pharmaceuticals Product
Table 132. Koye Pharmaceuticals Recent Development
Table 133. MSN Laboratories Corporation Information
Table 134. MSN Laboratories Description and Business Overview
Table 135. MSN Laboratories Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. MSN Laboratories Product
Table 137. MSN Laboratories Recent Development
Table 138. Wockhardt Corporation Information
Table 139. Wockhardt Description and Business Overview
Table 140. Wockhardt Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 141. Wockhardt Product
Table 142. Wockhardt Recent Development
Table 143. Incepta Pharmaceuticals Corporation Information
Table 144. Incepta Pharmaceuticals Description and Business Overview
Table 145. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 146. Incepta Pharmaceuticals Product
Table 147. Incepta Pharmaceuticals Recent Development
Table 148. Unimed Unihealth Corporation Information
Table 149. Unimed Unihealth Description and Business Overview
Table 150. Unimed Unihealth Pirfenidone Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 151. Unimed Unihealth Product
Table 152. Unimed Unihealth Recent Development
Table 153. Pirfenidone Market Trends
Table 154. Pirfenidone Market Drivers
Table 155. Pirfenidone Market Challenges
Table 156. Pirfenidone Market Restraints
Table 157. Pirfenidone Customers List
Table 158. Pirfenidone Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Pirfenidone Product Picture
Figure 2. Global Pirfenidone Sales Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pirfenidone Sales Market Share by Application in 2020 & 2027
Figure 7. Mild Idiopathic Pulmonary Fibrosis
Figure 8. Moderate Idiopathic Pulmonary Fibrosis
Figure 9. Other
Figure 10. Pirfenidone Report Years Considered
Figure 11. Global Pirfenidone Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pirfenidone Market Size 2016-2027 (US$ Million)
Figure 13. Global Pirfenidone Sales 2016-2027 (K Pcs)
Figure 14. Global Pirfenidone Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Pirfenidone Sales Market Share by Region (2016-2021)
Figure 16. Global Pirfenidone Sales Market Share by Region in 2020
Figure 17. Global Pirfenidone Revenue Market Share by Region (2016-2021)
Figure 18. Global Pirfenidone Revenue Market Share by Region in 2020
Figure 19. Global Pirfenidone Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Pirfenidone Revenue in 2020
Figure 21. Pirfenidone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Pirfenidone Sales Market Share by Type (2016-2021)
Figure 23. Global Pirfenidone Sales Market Share by Type in 2020
Figure 24. Global Pirfenidone Revenue Market Share by Type (2016-2021)
Figure 25. Global Pirfenidone Revenue Market Share by Type in 2020
Figure 26. Global Pirfenidone Sales Market Share by Application (2016-2021)
Figure 27. Global Pirfenidone Sales Market Share by Application in 2020
Figure 28. Global Pirfenidone Revenue Market Share by Application (2016-2021)
Figure 29. Global Pirfenidone Revenue Market Share by Application in 2020
Figure 30. Japan Pirfenidone Sales Growth Rate 2016-2027 (K Pcs)
Figure 31. Japan Pirfenidone Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Pirfenidone Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Pirfenidone Players Market Share by Revenue in Pirfenidone in 2020
Figure 34. Japan Pirfenidone Revenue Share by Type (2016-2021)
Figure 35. Japan Pirfenidone Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Pirfenidone Revenue Share by Application (2016-2021)
Figure 37. Japan Pirfenidone Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Pirfenidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 39. North America Pirfenidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Pirfenidone Sales Market Share by Country in 2020
Figure 41. North America Pirfenidone Revenue Market Share by Country in 2020
Figure 42. U.S. Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 43. U.S. Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 45. Canada Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Pirfenidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 47. Europe Pirfenidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Pirfenidone Sales Market Share by Country in 2020
Figure 49. Europe Pirfenidone Revenue Market Share by Country in 2020
Figure 50. Germany Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 51. Germany Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 53. France Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 55. U.K. Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 57. Italy Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 59. Russia Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Pirfenidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 61. Asia Pacific Pirfenidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Pirfenidone Sales Market Share by Region in 2020
Figure 63. Asia Pacific Pirfenidone Revenue Market Share by Region in 2020
Figure 64. China Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 65. China Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 67. Japan Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 69. South Korea Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 71. India Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 73. Australia Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 75. Taiwan Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 77. Indonesia Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 79. Thailand Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 81. Malaysia Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 83. Philippines Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 85. Vietnam Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Pirfenidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 87. Latin America Pirfenidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Pirfenidone Sales Market Share by Country in 2020
Figure 89. Latin America Pirfenidone Revenue Market Share by Country in 2020
Figure 90. Mexico Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 91. Mexico Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 93. Brazil Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 95. Argentina Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Pirfenidone Sales Growth Rate 2016-2021 (K Pcs)
Figure 97. Middle East and Africa Pirfenidone Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Pirfenidone Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Pirfenidone Revenue Market Share by Country in 2020
Figure 100. Turkey Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 101. Turkey Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 103. Saudi Arabia Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Pirfenidone Sales Growth Rate (2016-2021) (K Pcs)
Figure 105. U.A.E Pirfenidone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Pirfenidone Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Idiopathic Pulmonary Fibrosis Drug Market Insights and Forecast to 2028
    Published: 14-Jan-2022        Price: US 4900 Onwards        Pages: 90
    Idiopathic Pulmonary Fibrosis Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Idiopathic Pulmonary Fibrosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Glucocorticoid - Immunosuppressive Agent - Others ......
  • Global Idiopathic Pulmonary Fibrosis (IPF) Market - Analysis By Drug Type, End User, By Region, By Country (2021 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2021-2026)
    Published: 31-Dec-2021        Price: US 2400 Onwards        Pages: 220
    Executive Summary According to Azoth Analytics research report, the global Idiopathic Pulmonary Fibrosis Market is projected to display robust growth valued at USD 3271.3 Million in the year 2020 with North America leading the regional market share. The primary driver of growth in the IPF market in recent years has been an increased use of the high-priced Pirfenidone (Esbriet) and Nintedanib (Ofev) brands in favour of off-label pharmacological therapies and non-phar......
  • Pneumonia Therapeutics Market - Global Outlook and Forecast 2021-2027
    Published: 20-Nov-2021        Price: US 3250 Onwards        Pages: 90
    This report contains market size and forecasts of Pneumonia Therapeutics in Global, including the following market information: Global Pneumonia Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global Pneumonia Therapeutics market was valued at 12350 million in 2020 and is projected to reach US$ 15840 million by 2027, at a CAGR of 6.4% during the forecast period. MARKET MONITOR GLOBAL, INC (MMG) has survey......
  • Idiopathic Pulmonary Fibrosis Market - Global Outlook and Forecast 2021-2027
    Published: 04-Nov-2021        Price: US 3250 Onwards        Pages: 90
    This report contains market size and forecasts of Idiopathic Pulmonary Fibrosis in Global, including the following market information: Global Idiopathic Pulmonary Fibrosis Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five companies in 2020 (%) The global Idiopathic Pulmonary Fibrosis market was valued at 1781.8 million in 2020 and is projected to reach US$ 2523.6 million by 2027, at a CAGR of 9.1% during the forecast period. MARKET MONITOR GLOBA......
  • China Idiopathic Pulmonary Fibrosis Drug Market Report & Forecast 2021-2027
    Published: 21-Oct-2021        Price: US 3400 Onwards        Pages: 90
    China Idiopathic Pulmonary Fibrosis Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Idiopathic Pulmonary Fibrosis Drug Market Segment Percentages, By Type, 2020 (%) - Glucocorticoid - Immunosuppressive Agent - Others China Idiopathic Pulmonary Fibrosis Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Idiopathic Pulmonary Fibrosis Drug Market Segment Percentages, By Application, 2020 (%) -......
  • Global and Japan Pirfenidone Market Insights, Forecast to 2027
    Published: 20-Oct-2021        Price: US 3900 Onwards        Pages: 140
    Pirfenidone market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pirfenidone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Pirfenidone market size by player......
  • Global and China Pneumonia Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 12-Oct-2021        Price: US 3900 Onwards        Pages: 96
    Global Pneumonia Therapeutics Scope and Market Size Pneumonia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by......
  • United States Idiopathic Pulmonary Fibrosis Drug Market Report & Forecast 2021-2027
    Published: 07-Oct-2021        Price: US 3400 Onwards        Pages: 93
    United States Idiopathic Pulmonary Fibrosis Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT) United States Idiopathic Pulmonary Fibrosis Drug Market Segment Percentages, By Type, 2020 (%) - Glucocorticoid - Immunosuppressive Agent - Others United States Idiopathic Pulmonary Fibrosis Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT) United States Idiopathic Pulmonary Fibrosis Drug Market Segment Percentages, B......
  • Global and United States Idiopathic Pulmonary Fibrosis Market Size, Status and Forecast 2021-2027
    Published: 01-Oct-2021        Price: US 3900 Onwards        Pages: 99
    Global Idiopathic Pulmonary Fibrosis Scope and Market Size Idiopathic Pulmonary Fibrosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Idiopathic Pulmonary Fibrosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs